Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Copper intake via food and water can accelerate growth of tumors

Copper imbalances have been associated with a number of pathological conditions, including cancer. Publishing in PNAS scientists at EPFL have found that copper in drinking water - given at the maximum levels permitted in public water supplies - accelerated the growth of tumors in mice. On the other hand, reducing copper levels reduced tumor growth.

15 Nov 2013

Study finds link between alcohol consumption and reduced condom use among college women

A new study from researchers at The Miriam Hospital finds a link between alcohol consumption and reduced condom use among college women. The findings also indicate that women who smoke marijuana with established romantic partners may use condoms less often.

15 Nov 2013

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

After years of planning, construction and preparation, Kaiser Permanente will open the doors to a brand new specialty center in Lone Tree on December 2nd. This is the largest construction project and the most significant addition to the health plan's brick-and-mortar presence in Colorado in nearly a decade.

15 Nov 2013

Sorrento Therapeutics to acquire San Diego-based Concortis Biosystems

Sorrento Therapeutics, Inc. announced today the entry into a definitive agreement to acquire San Diego-based Concortis Biosystems, Corp. in a deal that provides Sorrento with a comprehensive technology platform for generation of antibody drug conjugates (ADC). Under the terms of the agreement dated November 11, 2013, subject to satisfaction of certain closing conditions, upon closing, Sorrento will issue an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders.

14 Nov 2013

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Cancer can be treated by a number of different ways depending on the location, grade and stage of tumour. A patient's age, medical history and lifestyle will also be taken into consideration and a combination of treatments will also be adopted to provide maximum effect.

14 Nov 2013

Over 50% of nonsurgical patients prescribed opioids during hospitalizations, analysis finds

Amid a growing climate of concern regarding the overuse of opioid pain medications, a comprehensive analysis of more than 1 million hospital admissions has found that over 50 percent of all nonsurgical patients were prescribed opioids during their hospitalizations -- often at very high doses -- and that more than half of those exposed were still receiving these medications on the day they were discharged from the hospital.

14 Nov 2013

African American men have higher risk of developing prostate cancer than European American men

African American men have a 60 percent higher risk of developing prostate cancer than European American men, and a 2.4 times higher risk of dying from the disease. Some of the reasons can be attributed to differences in screening practices and treatment, but further research is needed to determine more explicit explanations.

14 Nov 2013

Single dose of intranasal insulin can help improve cognitive function in diabetes patients

In recent years, the link between type 2 diabetes and dementia has become widely recognized. Older individuals with diabetes develop Alzheimer's disease at an earlier age, and are more likely to develop vascular dementia than people who do not have diabetes.

14 Nov 2013

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma, a rare and aggressive type of blood cancer.

13 Nov 2013

immatics, Roche enter into cancer vaccine and immunotherapy deal

immatics biotechnologies GmbH and Roche today announced a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics.

13 Nov 2013

Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients

Viewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema--a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.

13 Nov 2013

Merck Serono signs co-development and commercialization agreement for BeiGene-290

Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a biotech research and development company in Beijing, China.

13 Nov 2013

XTANDI now accepted for use within NHS Scotland for treatment of adult men with mCRPC

The Scottish Medicines Consortium, which advises NHS Scotland on prescribing new treatments, announced today that XTANDI (enzalutamide) is accepted for unrestricted use within NHS Scotland for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.

13 Nov 2013

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Swiss-based Helsinn group has granted Chugai Pharma Marketing Ltd., a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd., exclusive commercialization rights to their innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.

12 Nov 2013

Zalicus announces top-line results from Z160 Phase 2 clinical studies in chronic pain indications

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced top-line results from two Phase 2 clinical studies of Z160 in chronic pain indications.

11 Nov 2013

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.

11 Nov 2013

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Two new studies, published in The Lancet and The Lancet Oncology, show that targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures – which require women to attend daily radiotherapy sessions for weeks after surgery – for some women undergoing surgery for early breast cancer.

11 Nov 2013

Chindex International third quarter 2013 revenue increases 16% to $43.1 million

Chindex International, Inc., an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced financial results for the third quarter of 2013 ended September 30, 2013.

11 Nov 2013

Risk of dangerous bloodstream infections can be reduced in newborns with central venous catheters

A new study led by Johns Hopkins Children's Center investigators shows that clinicians can reduce the risk of dangerous bloodstream infections in newborns with central venous catheters by ending use of the device as soon as possible, rather than waiting for signs of infection.

11 Nov 2013

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Walter Quan, Jr., MD Chief of Medical Oncology and Director of Immunotherapy at Cancer Treatment Centers of America- Western Regional Medical Center is presenting new findings that are showing a major benefit to cancer patients.

11 Nov 2013

Oncology News and Research

Further Reading

Copper intake via food and water can accelerate growth of tumors

Study finds link between alcohol consumption and reduced condom use among college women

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

Sorrento Therapeutics to acquire San Diego-based Concortis Biosystems

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Over 50% of nonsurgical patients prescribed opioids during hospitalizations, analysis finds

African American men have higher risk of developing prostate cancer than European American men

Single dose of intranasal insulin can help improve cognitive function in diabetes patients

Imbruvica gets FDA approval for treatment of mantle cell lymphoma

immatics, Roche enter into cancer vaccine and immunotherapy deal

Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients

Merck Serono signs co-development and commercialization agreement for BeiGene-290

XTANDI now accepted for use within NHS Scotland for treatment of adult men with mCRPC

Helsinn grants exclusive commercialization rights to Chugai Pharma Marketing for anamorelin drug

Zalicus announces top-line results from Z160 Phase 2 clinical studies in chronic pain indications

Delmar Pharmaceuticals announces quarterly update, strengthens intellectual property portfolio

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Chindex International third quarter 2013 revenue increases 16% to $43.1 million

Risk of dangerous bloodstream infections can be reduced in newborns with central venous catheters

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News